Divi's Laboratories Limited

NSEI:DIVISLAB Stock Report

Market Cap: ₹894.1b

Divi's Laboratories Past Earnings Performance

Past criteria checks 2/6

Divi's Laboratories has been growing earnings at an average annual rate of 7.9%, while the Life Sciences industry saw earnings growing at 8.8% annually. Revenues have been growing at an average rate of 10.6% per year. Divi's Laboratories's return on equity is 10.9%, and it has net margins of 18.5%.

Key information

7.9%

Earnings growth rate

7.9%

EPS growth rate

Life Sciences Industry Growth11.2%
Revenue growth rate10.6%
Return on equity10.9%
Net Margin18.5%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Divi's Laboratories Limited (NSE:DIVISLAB) Not Flying Under The Radar

Dec 27
Divi's Laboratories Limited (NSE:DIVISLAB) Not Flying Under The Radar

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00

Aug 04
Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00

Jul 20
Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00

Divi's Laboratories (NSE:DIVISLAB) Has Announced A Dividend Of ₹30.00

Jul 06
Divi's Laboratories (NSE:DIVISLAB) Has Announced A Dividend Of ₹30.00

Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?

Nov 08
Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?

Divi's Laboratories (NSE:DIVISLAB) Is Increasing Its Dividend To ₹30.00

Aug 04
Divi's Laboratories (NSE:DIVISLAB) Is Increasing Its Dividend To ₹30.00

Divi's Laboratories' (NSE:DIVISLAB) Shareholders Will Receive A Bigger Dividend Than Last Year

Jul 21
Divi's Laboratories' (NSE:DIVISLAB) Shareholders Will Receive A Bigger Dividend Than Last Year

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Larger Dividend Than Last Year At ₹30.00

Jul 07
Divi's Laboratories (NSE:DIVISLAB) Will Pay A Larger Dividend Than Last Year At ₹30.00

Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Might Deserve Your Attention Today

Jul 03
Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Might Deserve Your Attention Today

Does Divi's Laboratories (NSE:DIVISLAB) Deserve A Spot On Your Watchlist?

Apr 03
Does Divi's Laboratories (NSE:DIVISLAB) Deserve A Spot On Your Watchlist?

Should You Be Adding Divi's Laboratories (NSE:DIVISLAB) To Your Watchlist Today?

Dec 23
Should You Be Adding Divi's Laboratories (NSE:DIVISLAB) To Your Watchlist Today?

With EPS Growth And More, Divi's Laboratories (NSE:DIVISLAB) Is Interesting

Sep 02
With EPS Growth And More, Divi's Laboratories (NSE:DIVISLAB) Is Interesting

Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Is Well Worth Watching

Mar 25
Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Is Well Worth Watching

Do Institutions Own Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Mar 10
Do Institutions Own Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Who Has Been Selling Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Feb 23
Who Has Been Selling Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Is Divi's Laboratories' (NSE:DIVISLAB) Share Price Gain Of 216% Well Earned?

Jan 25
Is Divi's Laboratories' (NSE:DIVISLAB) Share Price Gain Of 216% Well Earned?

Is Divi's Laboratories Limited's(NSE:DIVISLAB) Recent Stock Performance Tethered To Its Strong Fundamentals?

Jan 07
Is Divi's Laboratories Limited's(NSE:DIVISLAB) Recent Stock Performance Tethered To Its Strong Fundamentals?

Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?

Dec 20
Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?

What Type Of Shareholders Own The Most Number of Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Dec 03
What Type Of Shareholders Own The Most Number of Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Revenue & Expenses Breakdown
Beta

How Divi's Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:DIVISLAB Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2374,92613,83410,6700
30 Sep 2373,45613,31410,3800
30 Jun 2372,90614,77410,0400
31 Mar 2377,67618,2349,8700
31 Dec 2283,35323,9719,8510
30 Sep 2291,20829,9259,9080
30 Jun 2292,53831,0549,8270
31 Mar 2289,59929,6059,5710
31 Dec 2182,29725,6789,1540
30 Sep 2174,37921,3629,0440
30 Jun 2171,99620,4938,7360
31 Mar 2169,69519,8438,3670
31 Dec 2065,71018,7057,9500
30 Sep 2062,65817,5907,1790
30 Jun 2059,62015,9626,6410
31 Mar 2053,94513,7656,3170
31 Dec 1952,71912,8035,9950
30 Sep 1952,35613,1065,8240
30 Jun 1951,13913,5755,6940
31 Mar 1949,46313,5275,5250
31 Mar 1838,9158,7704,6510
31 Mar 1740,64310,6045,0900
31 Mar 1637,76411,2583,669277
31 Mar 1531,0498,5152,927252
31 Mar 1425,2677,7333,173229
31 Mar 1321,4136,0202,841220

Quality Earnings: DIVISLAB has high quality earnings.

Growing Profit Margin: DIVISLAB's current net profit margins (18.5%) are lower than last year (28.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: DIVISLAB's earnings have grown by 7.9% per year over the past 5 years.

Accelerating Growth: DIVISLAB's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: DIVISLAB had negative earnings growth (-42.3%) over the past year, making it difficult to compare to the Life Sciences industry average (0.9%).


Return on Equity

High ROE: DIVISLAB's Return on Equity (10.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.